Singapore and New York, September 16, 2026
KELLS, Inc. has announced that its KELLS AI Dental Scan has been registered as a Class B medical device with Singapore’s Health Sciences Authority (HSA), marking a significant regulatory milestone for the company’s artificial intelligence-powered dental screening technology. The registration makes the KELLS AI Dental Scan the company’s first HSA-registered AI dental screening tool designed for direct consumer use in Singapore. The development supports KELLS’ international expansion and reflects the growing role of artificial intelligence, digital health and medical imaging technologies in preventive oral healthcare.
KELLS AI Dental Scan Advances Digital Dental Screening
The KELLS AI Dental Scan is designed to allow individuals to capture images of their teeth using a smartphone, after which the company’s proprietary artificial intelligence technology analyzes the images for potential oral health concerns. The platform is intended to help users understand their dental health, recognize issues that may require attention and determine when consultation with a dental professional may be appropriate. By bringing dental screening capabilities beyond traditional clinical environments, the technology is designed to support a more accessible and continuous approach to oral health monitoring.
The Singapore registration represents an important step in the development and commercialization of AI-enabled dental care technologies. Unlike conventional dental assessments that generally take place during scheduled visits, smartphone-based screening can potentially allow users to monitor their oral health between appointments. KELLS said its technology is intended to extend oral health assessment into homes, workplaces and community settings, particularly for populations that may face challenges accessing regular dental evaluations.
AI Technology Supports Earlier Oral Health Insights
KELLS is positioning its AI Dental Scan as part of a broader digital dental care model focused on helping consumers identify potential concerns earlier and connect with professional care when appropriate. The company’s technology combines AI-powered image analysis with a digital care experience intended to support users throughout their oral health journey, from understanding current dental health to monitoring changes over time and navigating access to dental providers.
The company said the technology has already been deployed in Singapore through community and corporate oral health initiatives, demonstrating potential applications for large-scale digital screening. Such approaches could provide healthcare organizations and employers with additional tools for reaching populations outside conventional dental practices while helping direct individuals who may need additional assessment toward dental professionals.
Singapore Registration Supports Global Expansion
The Class B medical device registration with Singapore HSA also represents a broader regulatory and commercial milestone for KELLS as it expands its AI-powered dental technology internationally. The company said it has developed its technology around a quality management and clinical validation framework designed to support responsible applications of artificial intelligence in healthcare. Regulatory registration can be an important step for digital health technologies seeking to move from development and validation toward broader clinical and consumer deployment. KELLS Co-Founder and CEO Jie Feng said the company’s goal is to make oral health more measurable, understandable and actionable. The company envisions AI as a tool that can help consumers identify potential concerns and make more informed decisions about when and where to seek professional dental care. The Singapore milestone therefore highlights the expanding intersection of artificial intelligence, medical devices, digital dentistry and preventive healthcare.
As AI-powered healthcare technologies continue to enter regulated markets, the KELLS registration demonstrates how digital dental screening is becoming an emerging area within the broader MedTech landscape. The development could further support the adoption of smartphone-based oral health assessment while emphasizing the importance of regulatory oversight, clinical validation and appropriate professional follow-up in AI-enabled healthcare.
Source: KELLS press release



